Continuity on the Management Board of Bertrandt AG Ehningen, March 24, 2023 – Continuity on the Management Board of Bertrandt AG. Michael Lücke (Member of the Management Board – Sales) and Markus Ruf (Member of the Management Board – Finance) have been confirmed in their positions and have been appointed for a further five years.… Read More »
Longstanding customer prepares to grow cellular backhaul services and address new markets with network upgrade Herndon, Va., December 13, 2022 – ST Engineering iDirect, a global leader in satellite communications, has announced that its longstanding partner, the Bolivian Space Agency (ABE), a public company of the Plurinational State of Bolivia, has upgraded its satellite ground… Read More »
Interest in psychedelics as therapeutics has risen in recent years, spurred by studies that have found that the once-maligned drugs used in conjunction with therapy can help in the treatment of psychiatric patients. Amid a rush to commercialize a suite of newly-developed products, Massachusetts General Hospital (MGH) has begun a new Center for the Neuroscience… Read More »
With its $ 63 billion merger with Allergan in the rearview, the new AbbVie is facing a major challenge as U.S. biosimilars for Humira cast a pall over the near-term future. But AbbVie figures its homegrown prospects will keep driving growth—and a couple of surprises from Allergan could make the forecast even rosier. After six… Read More »
Akorn Pharmaceuticals, whose finances unraveled after manufacturing issues bombed a $ 4.3 billion buyout by Fresenius, is back at the negotiating table with lenders who are keeping it afloat. In a two-sentence announcement, the Lake Forest, Illinois-based drugmaker Monday said that “negotiations with certain of its lenders are ongoing following the expiration of its standstill… Read More »